Cancer

Why is The Breast Cancer Survival Rate Among Black Women So Low

Black women have a higher rate of breast cancer than White women, but they also have a lower survival rate. Dr. Shaina Rozell explains why this is the case. MD Newsline: Why is the breast cancer survival rate among black women so low compared to their White counterparts? Dr. Rozell: I think there are a...

Does Having a Family History of Breast Cancer Increase One's Risk?

In this interview, Dr. Shaina Rozell discusses the role of genetics in breast cancer. She talks about whether or not having a family history of breast cancer increases one’s risk. She also shares her thoughts on how knowing your risk factors will affect your decision-making process if you’re considering genetic testing for breast cancer. MDNewsline:...

Reasons Black Women are More Likely to Have Cancer That Metastasizes

We know that Black Women are more likely to be diagnosed with breast cancer than White women.   But did you know that black women are also more likely to have cancer that metastasizes? In this article, we’ll look at the reasons why. MD Newsline: Why are women of color more likely to have cancer...

Abdominal Radical Hysterectomy Versus Radiochemotherapy for Stage IB3 Cervical Cancer

Abdominal radical hysterectomy (ARH) is superior to radiochemotherapy (R-CT) in patients diagnosed with stage IB3 cervical cancer, according to the FIGO 2018 staging system, based on higher DFS and 5-year OS rates. Cervical cancer is a prevalent malignant condition of the genital tract of the female. It is the leading cause of death across the...

The Sociological and Genetic Roots of Racial Prostate Cancer Disparities

Black men exhibit higher rates of prostate cancer for many complex reasons. This article explores both the social and genetic factors at play. Among all forms of cancer, prostate cancer displays the widest racial disparities, which persist at every stage that the cancer presents. This article, published in Prostate Cancer and Prostatic Diseases, analyzes these...

Relationship Between Multiple Myeloma Spatio-Temporal Evolution, Treatment Type, and Relapse

The way that multiple myeloma cells distribute throughout the body can relate to treatment types and disease progression in various ways. Imaging can be a robust source of useful information in these cases. This article, published in Nature Communications, attempts to address the evolution of multiple myeloma (MM) in whole bone marrow, in order to...

Estimating Breast Cancer Overdiagnosis

Breast cancer diagnosis by mammography is an important step in detection, but overdiagnosis can also be an issue. Researchers find that overdiagnosis is fairly common. Breast cancer mammography screenings can lead to screen-detected breast cancer that, if not detected, would not have caused any signs or symptoms during the patient’s lifetime. There is no consensus...

Understanding the Link Between Breast Cancer and Obesity

Obesity has a demonstrable relationship to increased rates of breast cancer. Although the mechanisms are not fully clear, certain pathways towards improved treatment are suggested. Obesity, which is especially common in the United States, can promote both the onset and progression of numerous types of cancer, including breast cancer. Both breast cancer and obesity are...

Is Melanoma Treatment In Sight?

Melanoma: A Challenge Melanoma, a highly malignant type of skin cancer, is a significant health concern globally, with a median survival of 6 to 10 months. Researchers are actively investigating the cell signaling mechanisms that can affect tumour growth. Recently, the Institute of Cancer Research, London, reported on a significant scientific discovery. Researchers grew cells...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.